Antiviral Evaluation of Dispirotripiperazines against Hepatitis B Virus-Reference-Cited by-同舟云学术

Antiviral Evaluation of Dispirotripiperazines against Hepatitis B Virus

Published:2023-08-23 Issue:17 Volume:66 Page:12459-12467
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Jones Thane¹^ORCID,Tavis John E.²^ORCID,Li Qilan²,Riabova Olga³,Monakhova Natalia³,Bradley Daniel P.²,Lane Thomas R.¹^ORCID,Makarov Vadim³^ORCID,Ekins Sean¹^ORCID

Affiliation:

1. Collaborations Pharmaceuticals Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States

2. Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, Missouri 63104, United States

3. Research Center of Biotechnology RAS, Leninsky Prospekt 33-2, 119071 Moscow, Russia

Funder

National Institute of Neurological Disorders and Stroke

National Institute of Allergy and Infectious Diseases

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00974

Reference52 articles.

1. CDC. Hepatitis b, 2023. https://www.cdc.gov/nchs/fastats/hepatitis.htm (accessed May 25, 2023).

2. WHO. Hepatitis b, 2023. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (accessed May 25, 2023).

3. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

4. Hepatitis B therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Efficient Promising Direction for the Synthesis of Dispirotripiperazine (6-6-6 DSTP) Core;Synthesis;2024-06-26